Odyssey Health, Inc.
Odyssey Health, Inc.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Receivables Net Current | - | - | - | - | 0 | 0 | 0 | 0 | - | - | - | 0 | |||||
Other Receivables Gross Current | - | - | - | 0 | - | - | - | 0 | - | - | - | - | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||||
Investments | - | - | - | 0 | 0 | 0 | 0 | 1 | 13 | 14 | - | 0 | |||||
Finite Lived Intangible Assets Net | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 14 | 14 | 1 | 0 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | |||||
Accrued Salaries Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | |||||
Interest Payable Current | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Sold Under Agreements To Repurchase Repurch… | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Convertible Notes Payable Current | - | - | 0 | - | - | - | - | - | - | - | - | - | |||||
Notes And Loans Payable Current | 3 | 2 | - | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | |||||
Other Notes Payable Current | - | 0 | 0 | - | - | - | - | - | - | - | - | - | |||||
Derivative Liabilities Current | 2 | 4 | 0 | - | - | - | - | - | - | - | - | - | |||||
Convertible Debt Current | - | 2 | 1 | - | - | - | - | - | - | - | - | - | |||||
Liabilities Current | 10 | 11 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 5 | 7 | 7 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 54 | 54 | |||||
Retained Earnings Accumulated Deficit | -66 | -67 | -63 | -63 | -62 | -62 | -62 | -61 | -48 | -47 | -61 | -60 | |||||
Stockholders Equity | -10 | -11 | -7 | -7 | 7 | -6 | -6 | -5 | 8 | 9 | -6 | -6 | |||||
Liabilities And Stockholders Equity | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 14 | 14 | 1 | 0 | |||||
Finite Lived Intangible Assets Accumulated Amortiz… | - | - | - | - | - | - | - | - | 0 | 0 | 0 | - | |||||
Debt Instrument Unamortized Discount Current | - | 3 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | - | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 500 | 500 | 500 | 500 | - | 500 | 500 | 500 | 500 | 500 | 500 | 500 | |||||
Common Stock Shares Issued | 101 | 100 | 100 | 97 | 97 | 97 | 97 | 97 | 96 | 94 | 82 | 79 | |||||
Shares Outstanding | 101 | 100 | 100 | 97 | 97 | 97 | 97 | 97 | 96 | 94 | 82 | 79 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -17.50% | 80.00% | -5.00% | 18.87% | 7.55% | -66.04% | -14.29% | 0.00% | - | - | - | - |
| 2025 | -17.24% | -37.93% | -62.07% | 0.00% | -40.00% | 10.00% | 227.27% | 100.00% | 681.82% | -27.27% | -57.14% | -14.29% |
| 2024 | 0.00% | -18.00% | -49.00% | 21.95% | -26.83% | -26.83% | 30.61% | 18.37% | -26.53% | 40.00% | 25.00% | 10.00% |
| 2023 | - | - | - | - | - | - | -1.16% | 82.56% | 32.56% | -24.00% | 9.00% | -20.00% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.04 | 0.06 | 0.02 | 0.01 | 0.01 | 0.02 | 0.03 | 0.01 | 0.03 | 0.05 | 0.08 | 0.06 | |||||
| Quick Ratio | 0.03 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.02 | 0.04 | 0.07 | 0.05 | |||||
| Working Capital | -9.75M | -10.60M | -7.16M | -6.95M | -6.80M | -6.62M | -6.44M | -5.86M | -5.54M | -5.12M | -6.27M | -6.21M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.04 | -1.07 | -1.02 | -1.01 | 1.02 | -1.04 | -1.05 | -1.11 | 0.72 | 0.62 | -1.10 | -1.07 | |||||
| Interest Coverage TTM | -0.86 | -1.23 | -2.67 | -4.04 | -4.07 | -4.31 | -5.98 | -4.13 | -4.26 | -4.78 | -4.88 | -8.65 | |||||
| Debt Ratio | 27.08 | 15.69 | 50.82 | 140.87 | 41.74 | 25.22 | 19.41 | 10.10 | 0.42 | 0.38 | 11.16 | 14.51 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.02 | -0.04 | -0.01 | -0.02 | -0.14 | -0.14 | -0.01 | -0.01 | 0.11 | 0.09 | -0.05 | -0.07 | |||||
| Free Cash Flow Per Share TTM | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | -74.90% | -69.04% | -8.76% | 106.89% | -228.40% | -239.28% | -69.28% | -85.77% | -255.85% | -219.21% | -51.85% | -29.90% | |||||
| EPS Growth (1Y) | -75.68% | -69.94% | -9.90% | 91.79% | -227.27% | -222.34% | -76.24% | -87.88% | -224.88% | -206.00% | -51.92% | -24.54% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -1.72 | -1.69 | -6.50 | -1.32 | -0.04 | -0.16 | -1.50 | -4.96 | 0.37 | 0.71 | -1.94 | -1.96 | |||||
| P/B TTM | -0.63 | -0.73 | -1.10 | -0.33 | 0.09 | -0.36 | -0.32 | -0.78 | 0.51 | 0.87 | -1.34 | -1.88 | |||||
| Market Cap | 6.16M | 7.77M | 7.85M | 2.30M | 628.26K | 2.30M | 1.99M | 4.17M | 4.05M | 7.54M | 8.34M | 11.57M | |||||
| Enterprise Value | 5.86M | 8.92M | 9.40M | 2.28M | 625.07K | 2.30M | 1.94M | 4.17M | 3.98M | 7.38M | 8.15M | 11.54M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -934.98K | -620.46K | -382.88K | -347.39K | -362.83K | -542.96K | -1.40M | -1.22M | -1.27M | -1.25M | -1.25M | -1.48M | |||||
| Net Debt | -297.81K | 1.16M | 1.55M | -19.08K | -3.19K | -7.19K | -53.87K | -2.38K | -66.01K | -166.14K | -197.88K | -36.87K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Odyssey Health, Inc. (ODYY) — SEC Financial Statements & Analysis
Odyssey Health, Inc. (ODYY) is a surgical & medical instruments & apparatus company, incorporated in NV. Odyssey Health, Inc. trades on OTC as: ODYY. Based on its latest SEC filing (Form 10-Q, period ending 2026-04-30), Odyssey Health, Inc. reported a Debt-to-Equity ratio of -1.04x, a Price-to-Book (P/B) ratio of -0.63x (TTM), at a market cap of $6.16M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- -1.04x
- P/B TTM
- -0.63x
- Market Cap
- $6.16M
Data as of 2026-04-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Odyssey Health, Inc. in?
Odyssey Health, Inc. (ODYY) operates in the Surgical & Medical Instruments & Apparatus industry.
What is ODYY's market cap?
Odyssey Health, Inc. (ODYY) has a market capitalization of $6.16M as of 2026-04-30.
What exchange does ODYY trade on?
Odyssey Health, Inc. (ODYY) trades on the OTC.
Where is Odyssey Health, Inc. incorporated?
Odyssey Health, Inc. is incorporated in NV.